Very interesting, and that's for a pain killer. What will PAA be worth if MPL can decisively prove itself as a low toxicity, broad spectrum cancer treatment that successfully treats aggressive late stage "refractory" or resistant tumours that are usually regarded as terminal?
And then of course, there are the analogues that are yet to be fully explored and the non cancer possibilities of this mTor mechanism drug, like, say use in transplants or whatever that mTor drugs are used in?. hmmmmmm*
Peeteepoo's link again:
https://endpts.com/canine-club-elanco-animal-health-makes-takeover-play-for-partner-aratana-in-up-to-245m-deal/
* This stock is still a spec. Everything I said may turn out wrong. Don't be crazy in your allocations. DYOR
GLTAH
- Forums
- ASX - By Stock
- PAA
- Ann: Phase I Canine Repeat Dose MPL Demonstrates High Performance
Ann: Phase I Canine Repeat Dose MPL Demonstrates High Performance, page-14
Featured News
Add PAA (ASX) to my watchlist
(20min delay)
|
|||||
Last
20.5¢ |
Change
-0.020(8.89%) |
Mkt cap ! $81.16M |
Open | High | Low | Value | Volume |
20.0¢ | 21.0¢ | 19.5¢ | $331.9K | 1.617M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 440882 | 20.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
21.0¢ | 12736 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 203382 | 0.205 |
6 | 66109 | 0.200 |
8 | 103943 | 0.195 |
13 | 316871 | 0.190 |
5 | 424594 | 0.185 |
Price($) | Vol. | No. |
---|---|---|
0.210 | 7736 | 2 |
0.215 | 120000 | 1 |
0.235 | 25000 | 1 |
0.240 | 60977 | 5 |
0.245 | 41137 | 3 |
Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online